×

ACM Global Central Lab Expands to New Facility

US Specimen Processing Department moves to cater for growth in clinical trials


Rochester, NY, March 2, 2011 – ACM Global Central Lab, the global central laboratory that continually defines the customer-service standard with its flexible approach, today announced the specimen processing department at its US site, located in Rochester, NY, has completed a successful move into a new 7,200 square feet facility. The specimen processing department, responsible for opening packages containing specimens shipped to ACM for testing, sample Quality Control and specimen accessioning, has expanded into space next door to the main site to allow for the increase in workload and capacity.

The move to the new facility was prompted by the very strong growth in the demand for ACM’s clinical trials support services. The specimen processing department outgrew the space available in ACM’s headquarters. There are a total of 18 workstations available for specimen processing in the new space. Eleven new workstations were set up during construction and the final seven workstations were moved from 160 Elmgrove Park to the new building on January 14, 2011. The new facility can also hold over 20 freezers, including a liquid nitrogen tank available for specimen storage.

Renay Moore heads the department as Director of Clinical Trials Support Operations. Renay has been with ACM for over six years and was recently promoted from her role as a Senior Project Manager.

“We are excited to announce the expansion of the specimen processing department here in Rochester”, said Renay Moore. “This project started back in July 2010 and it’s thanks to the hardwork and support of our contractors and employees that the re-location has been carried out in such a timely manner.”


About ACM Global Central Laboratory
ACM Global Central Lab offers a flexible approach and a focus on precision to keep clinical research studies on schedule. ACM Global’s services extend to more than 60 countries with all tests conducted and managed from central lab facilities with seamless data management providing a single database. The organization performs 13 million tests each year, featuring more than 1,500 individual tests spanning all medical disciplines, including pathology, microbiology, flow cytometry and pharmacogenomics. Combining comprehensive safety, efficacy and pathology testing from a single lab ensures clients receive consistent, analyzable test results with faster and cleaner reporting. For more information, visit www.acmgloballab.com
 

email us at: info@acmgloballab.com
© ACM Global Laboratories 2017.
All rights reserved

HIPAA Privacy Statement